Danaher (NYSE:DHR) was downgraded by equities researchers at BidaskClub from a “hold” rating to a “sell” rating in a note issued to investors on Tuesday, July 25th.
DHR has been the subject of several other reports. Wells Fargo reiterated a “market perform” rating on shares of Danaher in a research note on Saturday, July 22nd. Credit Suisse Group reiterated a “buy” rating and issued a $93.00 price target on shares of Danaher in a research note on Wednesday, May 24th. Janney Montgomery Scott cut Danaher from a “buy” rating to a “neutral” rating in a research note on Wednesday, June 7th. Deutsche Bank reiterated a “buy” rating and issued a $97.00 price target on shares of Danaher in a research note on Wednesday, June 21st. Finally, Vetr upgraded Danaher from a “buy” rating to a “strong-buy” rating and set a $94.18 price target for the company in a research note on Thursday, April 20th. One investment analyst has rated the stock with a sell rating, four have given a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus target price of $102.18.
Shares of NYSE:DHR traded up $1.08 during trading on Tuesday, reaching $100.32. 300,257 shares of the stock were exchanged, compared to its average volume of 2,458,791. Danaher has a 12 month low of $78.97 and a 12 month high of $104.82. The stock has a market cap of $69,226.79, a PE ratio of 24.63, a P/E/G ratio of 1.91 and a beta of 1.03. The company has a quick ratio of 1.05, a current ratio of 1.43 and a debt-to-equity ratio of 0.39.
In other Danaher news, CFO Daniel L. Comas sold 62,989 shares of the company’s stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $101.96, for a total transaction of $6,422,358.44. Following the completion of the sale, the chief financial officer now directly owns 227,805 shares in the company, valued at $23,226,997.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Walter G. Lohr sold 10,578 shares of the company’s stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $97.90, for a total value of $1,035,586.20. Following the sale, the director now owns 19,821 shares of the company’s stock, valued at $1,940,475.90. The disclosure for this sale can be found here. Insiders have sold 313,260 shares of company stock valued at $31,657,786 over the last 90 days. Corporate insiders own 11.90% of the company’s stock.
Several large investors have recently made changes to their positions in the company. Green Square Capital LLC increased its stake in Danaher by 108.2% in the 4th quarter. Green Square Capital LLC now owns 10,557 shares of the conglomerate’s stock valued at $981,000 after buying an additional 5,486 shares during the last quarter. Xact Kapitalforvaltning AB increased its stake in shares of Danaher by 7.2% during the 4th quarter. Xact Kapitalforvaltning AB now owns 110,377 shares of the conglomerate’s stock worth $10,245,000 after purchasing an additional 7,412 shares during the last quarter. Handelsbanken Fonder AB purchased a new stake in shares of Danaher during the 4th quarter worth approximately $278,000. Envestnet Asset Management Inc. increased its stake in shares of Danaher by 4.2% during the 4th quarter. Envestnet Asset Management Inc. now owns 160,706 shares of the conglomerate’s stock worth $14,917,000 after purchasing an additional 6,547 shares during the last quarter. Finally, CNB Bank purchased a new stake in shares of Danaher during the 4th quarter worth approximately $116,000. Institutional investors own 77.65% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: This article was originally published by American Banking News and is the sole property of of American Banking News. If you are viewing this article on another domain, it was stolen and reposted in violation of international copyright and trademark laws. The original version of this article can be accessed at https://www.americanbankingnews.com/2018/04/16/bidaskclub-downgrades-danaher-dhr-to-sell.html.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.